| Health / Medical Topics |
PSA Prostate Cancer Vaccine
A peptide vaccine containing the prostate specific antigen (PSA) with potential antineoplastic activity. PSA, a glycoprotein secreted by prostatic epithelial and ductal cells, is overexpressed in prostate cancer cells and is used as a tumor marker for both diagnosis and treatment evaluation. Vaccination with PSA peptide vaccine may produce anti-PSA antibodies as well as elicit a cytotoxic T-cell (CTL) response against prostate cancer cells expressing this antigen, thereby decreasing tumor cell growth. (NCI Thesaurus)
YOU MAY ALSO LIKE
A rise in the blood level of PSA (prostate-specific antigen) in prostate cancer patients after treatment with surgery or radiation. PSA failure…
A brief rise and then fall in the blood level of PSA (prostate-specific antigen) that occurs in some patients 1-3 years after…
Any immunoglobulin that recognizes prostate-specific antigen.
A protein made by the prostate gland and found in the blood. PSA blood levels may be higher than normal in men…
A drug used to treat multiple myeloma. It is also used to treat mantle cell lymphoma in patients who have already received…
A targeted prodrug consisting of a recombinant modified form of the Aeromonas protoxin, proaerolysin (PA), bearing a prostate-specific protease cleavage site, with…
